Navigation Links
VaxGen Reports Financial Update
Date:3/6/2008

December 31,

2007 2006

Assets

Current assets:

Cash and cash equivalents:

Cash and commercial paper $ 64,726 $18,697

Reverse repurchase agreements - 54,378

Total cash and cash equivalents 64,726 73,075

Investment securities 6,889 24,668

Accounts receivable 199 516

Unbilled accounts receivable - 7,164

Due from related party - 284

Prepaid expenses and other current assets 1,167 2,544

Total current assets 72,981 108,251

Property and equipment, net 10,806 28,417

Restricted cash 1,556 2,895

Other assets 4,622 2,497

Total assets $89,965 $142,060

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable $2,151 $4,660

Accrued and other current liabilities 2,326 5,553

Derivative liability 3,500 8,220

Due to related party - 57

Total current liabilities 7,977 18,490

Convertible senior subordinated notes 30,679 30,321

Deferred rent and other liabilities 4,270 4,188

Total liabilities 42,926 52,999

Stockholders' equity:

Preferred sto
'/>"/>

SOURCE VaxGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. VaxGen to Present at the 10th Annual BIO CEO and Investor Conference
2. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
3. VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal
4. VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board
5. VaxGen Addresses MPM Claims in Letter to Stockholders
6. VaxGen Files Last Outstanding Periodic Report With SEC
7. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
8. VaxGen Files First Quarter 2007 Financials
9. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
10. VaxGen Files 2006 Financial Statements and Provides Cash Update
11. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...LE, Calif., Oct. 10 /- Neur...NTII ), today announced it will hold a,conference ...n the,Viprinex(TM) (ancrod) Phase 3 Trial Program ...e Paul E. Freiman, president and chief executive,o...cer., -- Date: Monday, October 13, 2008 -- Ti...
(Date:10/10/2008)...searchers in academia and industry reveal powerful...Lacromin) in mammalian cell culture lea...T COLLINS, Colo., Oct. 10 /- A recent...tro Cellular & Developmental Biology,revealed that..., http://www.Lacromin.com ) is a strong growth fac...
(Date:10/10/2008)...HRISTI, Texas, Oct. 10 /- C..., a technology management,company, announced the c...ent. The approval is on a key divisional applicati...ing High Frequency Electric Current,Therethrough" ...cts ("LTC"),platform tissue bonding/welding techno...
(Date:10/10/2008)...Mass., Oct. 10 /- Boston Sc... it has received approval from the,U.S. Food and D...ration,TAXUS(R) Liberte(R) Paclitaxel-Eluting Coro... TAXUS Liberte stent early next month in the Unite... of its TAXUS(R),Expresss2(TM) Atom(TM) Paclitaxel...
Breaking Biology Technology:Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 3Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 3
... ,>O. Rönn 1 , M. Landström 2 , A. Edm... 1 GE Healthcare, Uppsala, Sweden , ... Sweden , , ECL Plex™ Weste...t picogram levels, with linearity over 3.6 orders ...neously, and differential quantitation of low-abun...
...Introduction , High-throughput screening f...g development and a key application is in the area...upled receptors (GPCRs) (1). , <P ,>It i...han GPCRs of potential therapeutic value requiring...The Sigma-RBI Library of Pharmacologically Active ...
... 77, TE 70 PWR, TE 77 PWR , ECL™ Sem... electrophoretic transfer results using low curren..., • Units available with and withou...ity , • Complete, uniform electr...less than 1 h , • Minimal buffe...
... Key words: adenoviral vector • viral ...bull; gene delivery, , Biological ... greatly aid secondary screening as well as lead a...ts several challenges. Establishing stable cell sy...table levels is time-consuming. In addition, cellu...
Other Biology Technology:Detection and quantitation of low-abundant proteins with ECL Plex fluorescent Western blotting 2Detection and quantitation of low-abundant proteins with ECL Plex fluorescent Western blotting 3Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 2Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 3Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 4Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 5Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 6ECL Semi-dry Blotters 2Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 2Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 3Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 4Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 5Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 6Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 7Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 8Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 9Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 10
(Date:10/13/2008)...syth Institute, working with collaborators at Tuft...w control over embryonic stem cells, behavior. The...hanism within frog embryonic stem cells and trigge... growth, change in cell shape, and invasion of the...rical signals are a powerful control mechanism tha...
(Date:10/13/2008)...African chimpanzees living in Cte d,Ivoire, resear... dropped in numbers by a whopping 90 percent since...ew remaining chimpanzees are now highly fragmented...ional Park, according to a report in the October 1...cation. , This alarming decline in a country tha...
(Date:10/13/2008)...y different parts of the brain can come under atta...ding to a new study in mice with an MS-like diseas...nvading T cells dictates whether it,s the spinal c...from researchers at the University of Maryland Sch...sity in St. Louiswill be published online on Octob...
(Date:10/12/2008)...e in French . , Researchers at McGill Univers.... have identified two genetic variants in caucasia...ncrease the risk of male pattern baldness. Their r...ature Genetics. , About a third of all men are ...ondition,s social and economic impact is considera...
Breaking Biology News(10 mins):Forsyth scientists trigger cancer-like response from embryonic stem cells 2In a last 'stronghold' for endangered chimpanzees, survey finds drastic decline 2Researchers discover baldness gene: 1 in 7 men at risk 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 1Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 4For migrating sparrows kids have a compass but adults have the map 1116 1For migrating sparrows kids have a compass but adults have the map 1116 22007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 12007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 2HealthFitness Announces Third Quarter 2007 Financial Results 5565 1HealthFitness Announces Third Quarter 2007 Financial Results 5565 2HealthFitness Announces Third Quarter 2007 Financial Results 5565 3HealthFitness Announces Third Quarter 2007 Financial Results 5565 4HealthFitness Announces Third Quarter 2007 Financial Results 5565 5HealthFitness Announces Third Quarter 2007 Financial Results 5565 6HealthFitness Announces Third Quarter 2007 Financial Results 5565 7HealthFitness Announces Third Quarter 2007 Financial Results 5565 8HealthFitness Announces Third Quarter 2007 Financial Results 5565 9HealthFitness Announces Third Quarter 2007 Financial Results 5565 10HealthFitness Announces Third Quarter 2007 Financial Results 5565 11HealthFitness Announces Third Quarter 2007 Financial Results 5565 12HealthFitness Announces Third Quarter 2007 Financial Results 5565 13HealthFitness Announces Third Quarter 2007 Financial Results 5565 14HealthFitness Announces Third Quarter 2007 Financial Results 5565 15HealthFitness Announces Third Quarter 2007 Financial Results 5565 16
... Medical Center implanted Artificial Silicon Retin... treat vision loss caused by retinitis pigmentosa ...ameter and one-thousandth of an inch thick, less t...s had surgery Tuesday, January 25. The fifth patie... investigator Dr. John Pollack performed the surge...
...bright, light-emitting molecules have enabled rese...ter below the skin surface using only infrared lig...esearchers based at the University of Pennsylvania...scent materials called porphyrins within the surfa... a tumor within a living rodent. Their findings, w...
... to humane alternatives to the use of animals in r...wn that requires using animals as part of the test... Committee for Responsible Medicine, you invent yo... announced today that PCRM has developed the world...o measure insulin levels in individuals with diabe...
...searchers have identified several genetic changes ... help researchers better understand how and why pe...sue of the Journal of Neuroscience, researchers re...ion patterns regulated by alcohol in two mouse str...fer in a number of behavioral responses to acute a...
Other Biology News:Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss 2Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss 3Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin 2PCRM develops world's first cruelty-free insulin assay 2VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 2VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 3
Source of colony stimulating factors for assays of mouse hematopoietic progenitors from bone marrow, spleen, blood and fetal liver. Suitable for the growth of mouse BFU-E, CFU-M, CFU-G and CFU-GEMM
MagNA Pure LC Instrument from Roche Applied Science
Piperazine-N',N'-bis(2-ethanesulfonic acid), monosodium salt
...the principal excitatory neurotransmitter receptor...st: Ionotropic receptors, and metabotropic recepto...complexes of various subunits (GluR1-7, NMDA1-3, K.... Metabotropic glutamate receptors are G-protein c...
Biology Products: